In vivo evaluation of synthetic cannabinoid JWH-018 derivatives as potential new psychoactive substances
Open Access
- 11 May 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Synthetic cannabinoid receptor agonists constitute a prominent class of new psychoactive substances (NPS), in which minor structural modifications can markedly influence in vivo pharmacological outcomes. In this study, methoxy-substituted derivatives of JWH-018 were synthesized to examine the effect of substitution position on behavioral activity. JWH-018–5-OMe and JWH-018–6-OMe were evaluated using four in vivo assays, including catalepsy, hypothermia, analgesia, and locomotor activity. JWH-018–5-OMe selectively reduced rectal temperature, with limited effects observed in catalepsy, analgesia, and locomotor activity. Notably, JWH-018–6-OMe elicited robust and dose-dependent effects across all four behavioral endpoints, closely resembling the pharmacological profile of the parent compound, JWH-018 . Collectively, these results demonstrate that structural variations on the indole scaffold can produce measurable psychoactive effects, underscoring the importance of continued evaluation of indole-based synthetic cannabinoids within the NPS framework.Keywords
Funding Information
- National Research Foundation of Korea (RS-2024-00456616)
- National Research Foundation of Korea (RS-2025-00520453)
- National Research Foundation of Korea (RS-2024-0045661)
- Gyeongsangbuk-do RISE (2025-RISE-15-107)
- Institute for Information and Communications Technology Promotion (RS-2024-00459749)
This publication has 35 references indexed in Scilit:
- New psychoactive substances: a multidisciplinary review of challenges and their diverse characterDARU Journal of Pharmaceutical Sciences, 2025
- Legal responses to novel psychoactive substances implemented by ten European countries: An analysis from legal epidemiologyEmerging Trends in Drugs, Addictions, and Health, 2022
- Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluationsPsychopharmacology, 2021
- Cannabinoid‐Induced Tetrad in MiceCurrent Protocols in Neuroscience, 2017
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?Life Sciences, 2014
- Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testingAnalytical and Bioanalytical Chemistry, 2011
- Towards a better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad assayJournal of Ethnopharmacology, 2009
- Spice: A never ending story?Forensic Science International, 2009
- Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channelsNeurochemistry International, 2008
- Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemiaNeurochemistry International, 2006